Skip to content
10-K

Annual Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-24-000101

← back to feed
Filed
Apr 15, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 31, 2024 708K sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$8.93K
Operating Cash Flow FY 2023 · Dec 31, 2022 −$9.06K
Cash And Equivalents FY 2023 · Dec 31, 2023 $16.23K
Cash And Equivalents FY 2023 · Dec 31, 2022 $163
Stockholders Equity FY 2023 · Dec 31, 2023 −$447.2K
Stockholders Equity FY 2023 · Dec 31, 2022 −$411.34K
Stockholders Equity FY 2023 · Dec 31, 2021 −$377.59K
Current Liabilities FY 2023 · Dec 31, 2023 $463.44K
Current Liabilities FY 2023 · Dec 31, 2022 $411.5K
Total Liabilities FY 2023 · Dec 31, 2023 $463.44K
Total Liabilities FY 2023 · Dec 31, 2022 $411.5K
Current Assets FY 2023 · Dec 31, 2023 $16.23K
Current Assets FY 2023 · Dec 31, 2022 $163
Total Assets FY 2023 · Dec 31, 2023 $16.23K
Total Assets FY 2023 · Dec 31, 2022 $163
Eps Basic FY 2023 · Dec 31, 2023 $0.05
Eps Basic restated FY 2023 · Dec 31, 2022 −$0.05
Sga Expense FY 2023 · Dec 31, 2023 $14.93K
Sga Expense FY 2023 · Dec 31, 2022 $14.06K
Net Income FY 2023 · Dec 31, 2023 −$35.87K
Net Income FY 2023 · Dec 31, 2022 −$33.74K
Operating Income FY 2023 · Dec 31, 2023 −$14.93K
Operating Income FY 2023 · Dec 31, 2022 −$14.06K